Literature DB >> 8077915

Detection of human antibodies to Crimean-Congo haemorrhagic fever virus using expressed viral nucleocapsid protein.

A C Marriott1, T Polyzoni, A Antoniadis, P A Nuttall.   

Abstract

Diagnosis of Crimean-Congo haemorrhagic fever (CCHF) virus infections is hampered by the problems of handling this human pathogen, which requires the highest levels of biological containment. Recombinant antigens were examined for their potential as non-hazardous diagnostic reagents. The nucleocapsid (N) gene of the Greek AP92 isolate of CCHF virus was sequenced from cloned PCR products and the open reading frame was identified by homology to the N protein of a Chinese isolate of CCHF virus. The N protein was expressed to high levels in a baculovirus expression system. Three N protein-derived peptides were expressed in Escherichia coli as fusions with glutathione S-transferase and the antigenicities of these proteins and the baculovirus-expressed protein were tested by ELISA. When tested with laboratory animal sera representing all seven serogroups of nairoviruses, the only reactive sera were those raised to CCHF virus (Greek, Nigerian and Chinese isolates) and, more weakly, Hazara virus. When tested with a panel of known positive and negative human sera, the baculovirus-expressed N protein, and the peptide derived from the central region of the N protein, proved to be the best for identifying CCHF virus-specific IgG.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077915     DOI: 10.1099/0022-1317-75-9-2157

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Koji Sakai; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Cross-Reactive anti-Nucleocapsid Protein Immunity against Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus in Multiple Species.

Authors:  Merve Kalkan-Yazıcı; Elif Karaaslan; Nesibe Selma Çetin; Sevde Hasanoğlu; Filiz Güney; Ümit Zeybek; Mehmet Z Doymaz
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay.

Authors:  M F Saeed; M Nunes; P F Vasconcelos; A P Travassos Da Rosa; D M Watts; K Russell; R E Shope; R B Tesh; A D Barrett
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  Severe Crimean-Congo haemorrhagic fever presented with massive retroperitoneal haemorrhage that recovered without antiviral treatment.

Authors:  Mehrnaz Asadi Gharabaghi; Sadegh Chinikar; Seyyed Mojtaba Ghiasi; Maryam Morady; Taha Ahmadinejhad; Koosha Paydary
Journal:  BMJ Case Rep       Date:  2011-08-19

7.  [Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].

Authors:  P Vasileva; K Bozhkova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

8.  Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.

Authors:  J Ter Meulen; K Koulemou; T Wittekindt; K Windisch; S Strigl; S Conde; H Schmitz
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Detection of IgG antibody against Crimean-Congo haemorrhagic fever virus using ELISA with recombinant nucleoprotein antigens from genetically diverse strains.

Authors:  A Rangunwala; R R Samudzi; F J Burt
Journal:  Epidemiol Infect       Date:  2013-12-13       Impact factor: 4.434

10.  The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey.

Authors:  Kenan Midilli; Ayşen Gargili; Onder Ergonul; Murat Elevli; Sevgi Ergin; Nesrin Turan; Gönül Sengöz; Recep Ozturk; Mehmet Bakar
Journal:  BMC Infect Dis       Date:  2009-06-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.